Stem cell treatment for chronic kidney disease safety study
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your kidney function must be reduced (eGFR below 60).
- If you have diabetes, your blood sugar control (A1c) must be 9% or lower.
- You must not be on dialysis or have kidney failure needing dialysis.
- You must not have uncontrolled high blood pressure, recent heart problems, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.
This research study tests an experimental treatment for people with chronic kidney disease who are not yet on dialysis. The goal is to see if the treatment is safe and how it affects kidney function.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It may slow down kidney damage and improve kidney function.
This study tests whether giving special stem cells (called mesenchymal stem cells) can help improve poor graft function after a stem cell transplant. It aims to boost your blood cell counts so you recover better.
This study tests a special type of stem cell treatment called mesenchymal stromal cells (Amimestrocel) for patients with acute kidney injury. The goal is to see if this treatment can help kidneys recover better than standard care.
This trial tests whether a type of stem cell called mesenchymal stromal cells (Amimestrocel) can help people with diabetic kidney disease. It aims to see if the treatment is safe and can improve kidney function.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.